Ganciclovir treatment in Ménétrier's disease

V. Hoffer, Y. Finkelstein, J. Balter, M. Feinmesser, B. Z. Garty*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

A 2-y-old girl with severe edema, oliguria and hypoalbuminemia caused by protein-losing gastritis was diagnosed with cytomegalovirus-associated Ménétrier's disease. After almost two weeks, during which the patient required repeated albumin transfusions, she was treated with intravenous ganciclovir. Within five days her condition had improved, and no additional albumin replacement was needed. Complete recovery was observed after several weeks. Conclusion: In patients with severe Ménétrier's disease, a course of ganciclovir treatment may be of benefit and should be considered.

Original languageEnglish
Pages (from-to)983-985
Number of pages3
JournalActa Paediatrica, International Journal of Paediatrics
Volume92
Issue number8
DOIs
StatePublished - 1 Aug 2003

Keywords

  • Cytomegalovirus
  • Ganciclovir
  • Ménétrier's disease
  • Protein-losing gastritis

Fingerprint

Dive into the research topics of 'Ganciclovir treatment in Ménétrier's disease'. Together they form a unique fingerprint.

Cite this